Investors looking for stocks that could explode higher in 2021 have at least three options in the biotech space to consider right now.
Clinical trial data and decisions from the FDA could send shares of argenx (NASDAQ:ARGX), Axsome Therapeutics (NASDAQ:AXSM), and CRISPR Therapeutics (NASDAQ:CRSP) through the roof in 2021. Read on to find out how they can make it happen.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,